Clinical trials
Hypercholesterolemia is a specific type of hyperlipidemia characterized by high levels of low-density lipoprotein (LDL) cholesterol in the blood. It increases the risk of heart disease and can be inherited but is often preventable and treatable through a healthy diet, regular exercise, and medication. The Hypercholesterolemia Pipeline Insight 2025 report
Clinical trials
A comprehensive analysis of drugs approved by the USFDA for managing diabetes mellitus from 2013 to 2022 has shed light on the evolving landscape of DM care. This review, conducted by a team of researchers from the Dr. Kolpe Institute of Pharmacy - Pharmacology in Ahmednagar, India, provides insights into
Clinical trials
In a detailed study, researchers have shed light on the complexities of measuring the effectiveness of cancer treatments through progression-free survival (PFS) and overall survival (OS) endpoints. These endpoints, crucial in assessing therapeutic efficacy in oncology drug development, are frequently compromised by various factors, including protocol design, intercurrent events, and
Drugs
The United States is heavily dependent on China for many of the chemicals used to make medicines, with nearly 700 approved drugs relying on Chinese-produced chemicals. The US Pharmacopeia, a nonprofit that tracks the drug supply, released an analysis showing that China is the sole supplier of at least one
Drugs
The United States is heavily dependent on China for many of the chemicals used to make medicines, with nearly 700 approved drugs relying on Chinese-produced chemicals. The US Pharmacopeia, a nonprofit that tracks the drug supply, released an analysis showing that China is the sole supplier of at least one
Covert operations
The US has significantly escalated its drug war with Venezuelan President Nicolas Maduro, with President Trump authorizing the CIA to carry out lethal operations against Maduro's government. The move is part of the Trump administration's larger strategy to oust the authoritarian leader from power. The CIA&
AstraZeneca PLC
US President Donald Trump has announced a deal with AstraZeneca PLC that will lead to significantly lower domestic drug prices in exchange for granting the pharma giant tariff relief. The agreement requires AstraZeneca to charge "Most Favored Nation" pricing to Medicaid, the US health insurance programme for low-income
AstraZeneca PLC
US President Donald Trump announced that AstraZeneca will offer major discounts on its prescription drugs sold in the US, citing the "most favored nation" pricing clause. This means that Americans will pay the lowest price for AstraZeneca's drugs globally. Trump also revealed that AstraZeneca will invest
AstraZeneca PLC
AstraZeneca, one of the world's largest pharmaceutical companies, is poised to announce a drug pricing deal with President Trump, following a similar agreement made with Pfizer last week. The deal is expected to be disclosed at a White House event later Friday, although details remain unclear. This move
AstraZeneca PLC
President Donald Trump has announced that pharmaceutical company AstraZeneca will offer its prescription medications to the Medicaid program at the lowest prices available anywhere in the world, as part of the administration's effort to lower drug prices and reduce the burden on American taxpayers. This deal, which is
Drugs
The Trump administration is reportedly considering a regulatory process to force drugmakers to lower U.S. prices to match levels in other wealthy countries, a move that could cut deeply into pharmaceutical companies' profits. The proposal, outlined in a previously deleted and reposted notice, aims to establish a "
Drugs
President Trump has sharply intensified his administration's crackdown on Venezuelan drug cartels, accusing the country of sending the U.S. "gangs, drugs and dealers" in a latest attack. The September 2 strike on a suspected drug boat leaving Venezuela marked a significant escalation in the U.
